Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

IST/DEVA stock hub

IST/DEVA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/DEVAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.4B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/DEVA

In the news

Latest news · IST/DEVA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13.7P50 15.1P75 15.3

Trailing P/En/a

P25 16.6P50 25.2P75 56.6

ROE-3.6

P25 -2.4P50 3.5P75 11.2

ROIC-0

P25 -0.7P50 4.3P75 13.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/DEVA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

TRY

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	3,023
Employees Change	-40%
Employees Change Percent	-1.31
Enterprise value	TRY 16.6B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TRADEVAW91E2
Last refreshed	2026-05-10
Market cap	TRY 14.4B
Price	TRY 71.95
Price currency	TRY
Rev Per Employee	6,509,513.75x
Sector	Healthcare
Sic	2834
Symbol	ist/DEVA
Website	https://www.deva.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.41%
EV Earnings	-18.04x
EV/EBITDA	10.75x
EV/FCF	10.58x
EV/Sales	0.85x
FCF yield	10.92%
P/B ratio	0.5x
P/S ratio	0.73x
PE Ratio10 Y	14.68x
PE Ratio3 Y	34.31x
PE Ratio5 Y	21.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.58%
EBITDA Margin	7.86%
FCF margin	7.99%
Gross margin	32.24%
Gross Profit	TRY 6.3B
Gross Profit Growth	-21.97%
Gross Profit Growth Q	-19.36%
Gross Profit Growth3 Y	29.78%
Gross Profit Growth5 Y	44.21%
Net Income	TRY -922M
Net Income Growth Years	0%
Pretax Margin	1.13%
Profit Margin	-4.69%
Profit Per Employee	TRY -304,992
ROA	-0.19
Roa5y	4.18
ROCE	-0.35
ROE	-3.57
Roe5y	18.54
ROIC	-0.04
Roic5y	8.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	34.81%
Cagr15y	24.12%
Cagr1y	24.28%
Cagr20y	17.05%
Cagr3y	21.91%
Cagr5y	18.24%
Div CAGR10	9.6%
Div CAGR3	35.72%
Div CAGR5	20.11%
EPS Growth Years	0
FCF Growth	-42.23%
FCF Growth Q	112.57%
FCF Growth3 Y	62.45%
FCF Growth5 Y	66.09%
OCF Growth	-46.36%
OCF Growth Q	27.32%
OCF Growth10 Y	50.51%
OCF Growth3 Y	32.69%
OCF Growth5 Y	52.25%
Revenue Growth	-4.88x
Revenue Growth Q	-2.19x
Revenue Growth Quarters	4x
Revenue Growth Years	12x
Revenue Growth3 Y	30.23x
Revenue Growth5 Y	59.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.54
Assets	TRY 41.3B
Cash	TRY 4.4B
Current Assets	TRY 16.6B
Current Liabilities	TRY 10.1B
Debt	TRY 6.7B
Debt EBITDA	TRY 4.31
Debt Equity	TRY 0.23
Debt FCF	TRY 4.25
Equity	TRY 28.8B
Interest Coverage	-0.05
Liabilities	TRY 12.4B
Long Term Assets	TRY 24.6B
Long Term Liabilities	TRY 2.3B
Net Cash	TRY -2.2B
Net Cash By Market Cap	TRY -15.57
Net Debt EBITDA	TRY 1.45
Net Debt Equity	TRY 0.08
Net Debt FCF	TRY 1.43
Tangible Book Value	TRY 19.8B
WACC	-45.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2
Inventory Turnover	2.43
Net Working Capital	TRY 9.1B
Quick ratio	1.28
Working Capital	TRY 9.1B
Working Capital Turnover	TRY 3.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TRY 0
Last Dividend	TRY 0.25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,882.17%
1Y total return	24.27%
200-day SMA	66.04
3Y total return	81.19%
50-day SMA	64.44
50-day SMA vs 200-day SMA	50under200
5Y total return	131.05%
All Time High	106
All Time High Change	-32.12%
All Time High Date	2024-05-24
All Time Low	0.06
All Time Low Change	122,056.2%
All Time Low Date	1996-01-03
ATR	2.15
Beta	-0.15
Beta1y	0.54
Beta2y	0.36
Ch YTD	14.75
High	74.35
High52	81.75
High52 Date	2026-02-13
High52ch	-11.99%
Low	70.2
Low52	51
Low52 Date	2025-06-13
Low52ch	41.08%
Ma50ch	11.65%
Price vs 200-day SMA	8.95%
RSI	68.96
RSI Monthly	54.69
RSI Weekly	58.31
Sharpe ratio	0.59x
Sortino ratio	1.04
Tr YTD	14.75
Tr15y	2,457.26%
Tr1m	16.24%
Tr1w	11.55%
Tr3m	-4.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -113.2M
Operating margin	-0.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,594,527%
Net Borrowing	-270,409,027
Shares Institutions	1.35%
Shares Out	200,019,287
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY 1.6B
Average Volume	783,401.25x
CAPEX	TRY -475.5M
Ch10y	1,839.4
Ch15y	2,243.6
Ch1m	16.24
Ch1w	11.55
Ch1y	24.27
Ch20y	713
Ch3m	-4.13
Ch3y	79.97
Ch5y	128.4
Ch6m	4.05
Change	3.38%
Change From Open	2.35
Close	69.6
Days Gap	1.01
Depreciation Amortization	1,556,578,641
Dollar Volume	267,812,865.6
Earnings Date	2026-05-14
EBIT	TRY -113.2M
EBITDA	TRY 1.5B
F Score	4
FCF	TRY 1.6B
FCF EV Yield	9.45x
FCF Per Share	TRY 7.86
Financing CF	-1,416,354,425
Fiscal Year End	December
Founded	1,958
Goodwill	40,396,498
Income Tax	TRY 1.1B
Investing CF	1,528,353,235
Is Primary Listing	1
Last Earnings Date	2025-11-04
Last Report Date	2025-12-31
Last Split Date	2004-06-11
Last Split Type	Forward
Ma150	66
Ma150ch	9.02%
Ma20	67.09
Ma20ch	7.25%
Net CF	1,805,761,863
Next Earnings Date	2026-05-14
Open	70.3
P FCF Ratio	9.16
P OCF Ratio	7.03
Position In Range	42.17
Ppne	12,047,490,592
Price Date	2026-05-08
Price EBITDA	TRY 9.3
Ptbv Ratio	0.73
Relative Volume	5.96x
Revenue	19,678,260,077x
Tax By Revenue	5.81x
Tax Rate	515.31%
Tr20y	2,230.85%
Tr6m	4.05%
Volume	3,722,208

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IST/DEVA pay a dividend?

Capital-return profile for this ticker.

Performance

IST/DEVA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/DEVA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/DEVA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.0

Neutral momentum band

Price vs 200-day MA

+9.0%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/DEVA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/DEVA stock rating?

ist/DEVA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/DEVA analysis?

The full report lives at /stocks/ist/DEVA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/DEVA?

The latest report frames ist/DEVA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/DEVA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.